Immunology

Biotech Videos 

Vaccines were originally developed as a prophylactic agent, administered to healthy individuals to induce long-term immunity against a pathogen and to prevent the outbreak of viral diseases. Therapeutic vaccines aim at inducing strong antigen-specific T cell responses. In contrast to prophylactic vaccines, they are used in patients who already have a growing, established tumor. In the field of cancer immunotherapy, prophylactic vaccination only applies to the few virally induced malignancies, such as the vaccine against hepatitis B virus that can cause liver cancer, or the nowadays widespread human papilloma virus (HPV) vaccination of teenagers, which aims to prevent genital cancers induced by high-risk HPV strains.
https://www.creative-biolabs.com/vaccine/cancer-vaccines.htm

Cancer Vaccines

Coronaviruses are enveloped viruses with a positive-sense RNA genome and with a nucleocapsid of helical symmetry. Coronavirus nucleoproteins localize to the cytoplasm and the nucleolus, a subnuclear structure, in both virus-infected primary cells and in cells transfected with plasmids that express N protein.
https://www.creativebiolabs.net/symbolsearch_2019-nCoV%20NP.htm

Introduction to SARS-CoV-2

Thyroid cancer is cancer that develops from the tissues of the thyroid gland. It is a disease in which cells grow abnormally and have the potential to spread to other parts of the body. Symptoms can include swelling or a lump in the neck. Cancer can also occur in the thyroid after spread from other locations, in which case it is not classified as thyroid cancer.
https://www.creativebiolabs.net/thyroid-cancer-overview-signaling-pathway-diagnosis-targeted-therapy.htm

Thyroid Cancer Overview

Endometrial cancer is the most common gynecologic malignancy. It is the fourth most common cancer in women after breast, lung, and colorectal cancers. Endometrial cancer is generally classified into two types. Type I is the most common form, representing more than 70% of cases. Type I tumors are associated with unopposed estrogen stimulation and are known as endometrioid adenocarcinoma.
https://www.creativebiolabs.net/endometrial-cancer-overview-signaling-pathway-diagnosis-targeted-therapy.htm

Endometrial Cancer Overview

Pancreatic cancer is a highly malignant digestive system tumor whose etiology and pathogenesis are still unknown. Pancreatic cancer is a cancer that develops from pancreatic tissue. It is a disease in which pancreatic cells become cancerous and can invade other tissues and spread to other parts of the body. 
https://www.labtube.tv/account/upload

Pancreatic Cancer Overview

Prostate cancer is the development of cancer in the prostate, a small walnut-shaped gland in men that produces the seminal fluid that nourishes and transports sperm. Prostate cancer is the second most frequent malignancy (after lung cancer) in men worldwide. The incidence and mortality of prostate cancer worldwide correlate with increasing age with the average age at the time of diagnosis being 66 years. 
https://www.creativebiolabs.net/prostate-cancer-overview-signaling-pathway-diagnosis-targeted-therapy.htm

Prostate Cancer Overview

Therapeutic antibodies are monoclonal antibodies developed to attack specific cells or proteins for the treatment of a wide variety of diseases, including immune disorders, cancers, and infections. Currently, there are 65 monoclonal antibodies (mAbs) approved by FDA for clinical use and more than 350 are being evaluated in clinical trials. Therapeutic antibody development has entered a rapid growth phase in demand of therapeutic market, with recognition of their potential and unprecedented success.
https://www.creativebiolabs.net/therapeutic-antibodies-htm_10.htm

 Antibody based Cancer Therapies

Designing of an ADC is an elaborate process that involves careful planning, meticulous execution, and intensive trouble-shooting. https://www.creative-biolabs.com/adc/one-stop-adc-development-service.htm

Designing of an ADC

As one major component of an antibody-drug conjugate (ADC), the antibody is the key for target specificity and serves as the cargo to deliver the cytotoxic drug (payload). A payload drug can be attached to different sites on an antibody using diverse conjugation chemistry. Multiple endogenous amino acids can serve as potential conjugation sites. However, to achieve more precisely controlled site-directed conjugations and subsequently a narrower distribution of drug-to-antibody ratio (DAR), special moieties with unique conjugation chemistries are engineered into antibody sequences in our antibody design services.
https://www.creative-biolabs.com/adc/antibody-design-and-conjugation.htm

Immunology

Refine By

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.